These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 21216836

  • 1. Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.
    Zendaoui A, Lachance D, Roussel E, Couet J, Arsenault M.
    Circ Heart Fail; 2011 Mar; 4(2):207-13. PubMed ID: 21216836
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of beta-blockade in experimental chronic aortic regurgitation.
    Plante E, Lachance D, Gaudreau M, Drolet MC, Roussel E, Arsenault M, Couet J.
    Circulation; 2004 Sep 14; 110(11):1477-83. PubMed ID: 15353507
    [Abstract] [Full Text] [Related]

  • 3. Benefits of long-term beta-blockade in experimental chronic aortic regurgitation.
    Plante E, Lachance D, Champetier S, Drolet MC, Roussel E, Arsenault M, Couet J.
    Am J Physiol Heart Circ Physiol; 2008 Apr 14; 294(4):H1888-95. PubMed ID: 18296565
    [Abstract] [Full Text] [Related]

  • 4. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M, Podbregar M, Kovacic D, Rozman J, von Haehling S.
    Respir Med; 2011 Oct 14; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [Abstract] [Full Text] [Related]

  • 5. Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure overload: effects of beta-receptor blockade.
    Grimm D, Huber M, Jabusch HC, Shakibaei M, Fredersdorf S, Paul M, Riegger GA, Kromer EP.
    J Mol Cell Cardiol; 2001 Mar 14; 33(3):487-501. PubMed ID: 11181017
    [Abstract] [Full Text] [Related]

  • 6. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M, Covolo L, Pezzali N, Zacà V, Bugatti S, Lombardi C, Bettari L, Romeo A, Gelatti U, Giubbini R, Donato F, Dei Cas L.
    Cardiovasc Drugs Ther; 2010 Feb 14; 24(1):49-60. PubMed ID: 20352314
    [Abstract] [Full Text] [Related]

  • 7. Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.
    Zhao Q, Wu TG, Jiang ZF, Chen GW, Lin Y, Wang LX.
    Cardiovasc Drugs Ther; 2007 Apr 14; 21(2):85-90. PubMed ID: 17440824
    [Abstract] [Full Text] [Related]

  • 8. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K, Asari K, Saito M, Kawana J, Mita M, Ogata H.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):194-200. PubMed ID: 18534575
    [Abstract] [Full Text] [Related]

  • 9. Characterization of coronary flow reserve and left ventricular remodeling in a mouse model of chronic aortic regurgitation with carvedilol intervention.
    Wang X, Wu J, Zhu D, You J, Zou Y, Qian J, Ge J.
    J Ultrasound Med; 2015 Mar 28; 34(3):483-93. PubMed ID: 25715369
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
    Plante E, Gaudreau M, Lachance D, Drolet MC, Roussel E, Gauthier C, Lapointe E, Arsenault M, Couet J.
    Can J Physiol Pharmacol; 2004 Mar 28; 82(3):191-9. PubMed ID: 15052285
    [Abstract] [Full Text] [Related]

  • 11. Effects of spironolactone treatment on an experimental model of chronic aortic valve regurgitation.
    Zendaoui A, Lachance D, Roussel E, Couet J, Arsenault M.
    J Heart Valve Dis; 2012 Jul 28; 21(4):478-86. PubMed ID: 22953675
    [Abstract] [Full Text] [Related]

  • 12. Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems.
    Champetier S, Bojmehrani A, Beaudoin J, Lachance D, Plante E, Roussel E, Couet J, Arsenault M.
    Am J Physiol Heart Circ Physiol; 2009 Mar 28; 296(3):H669-77. PubMed ID: 19112094
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
    Plante E, Lachance D, Beaudoin J, Champetier S, Roussel E, Arsenault M, Couet J.
    Circ Heart Fail; 2009 Jan 28; 2(1):25-32. PubMed ID: 19808312
    [Abstract] [Full Text] [Related]

  • 14. Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.
    Armenian SH, Hudson MM, Chen MH, Colan SD, Lindenfeld L, Mills G, Siyahian A, Gelehrter S, Dang H, Hein W, Green DM, Robison LL, Wong FL, Douglas PS, Bhatia S.
    BMC Cardiovasc Disord; 2016 Oct 04; 16(1):187. PubMed ID: 27716152
    [Abstract] [Full Text] [Related]

  • 15. Carvedilol: use in chronic heart failure.
    Doughty RN, White HD.
    Expert Rev Cardiovasc Ther; 2007 Jan 04; 5(1):21-31. PubMed ID: 17187454
    [Abstract] [Full Text] [Related]

  • 16. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
    Yaoita H, Sakabe A, Maehara K, Maruyama Y.
    Circulation; 2002 Feb 26; 105(8):975-80. PubMed ID: 11864928
    [Abstract] [Full Text] [Related]

  • 17. Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
    Hirooka K, Yasumura Y, Ishida Y, Hanatani A, Nakatani S, Komamura K, Hori M, Yamagishi M, Miyatake K.
    Jpn Circ J; 2001 Nov 26; 65(11):931-6. PubMed ID: 11716241
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation.
    Arsenault M, Zendaoui A, Roussel E, Drolet MC, Dhahri W, Grenier A, Gascon S, Sarrhini O, Rousseau JA, Lecomte R, Couet J.
    Circ Heart Fail; 2013 Sep 01; 6(5):1021-8. PubMed ID: 23861486
    [Abstract] [Full Text] [Related]

  • 19. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP, Wei CP, Ma SC, Zhang YF, Qiao LY, Li DH, Shan RB.
    J Cardiovasc Pharmacol; 2015 May 01; 65(5):480-4. PubMed ID: 25945865
    [Abstract] [Full Text] [Related]

  • 20. Moderate exercise training improves survival and ventricular remodeling in an animal model of left ventricular volume overload.
    Lachance D, Plante E, Bouchard-Thomassin AA, Champetier S, Roussel E, Drolet MC, Arsenault M, Couet J.
    Circ Heart Fail; 2009 Sep 01; 2(5):437-45. PubMed ID: 19808374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.